ZA933567B - Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease - Google Patents
Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's diseaseInfo
- Publication number
- ZA933567B ZA933567B ZA933567A ZA933567A ZA933567B ZA 933567 B ZA933567 B ZA 933567B ZA 933567 A ZA933567 A ZA 933567A ZA 933567 A ZA933567 A ZA 933567A ZA 933567 B ZA933567 B ZA 933567B
- Authority
- ZA
- South Africa
- Prior art keywords
- fluoroallylamine
- fluorophenethyl
- alzheimer
- disease
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88867192A | 1992-05-27 | 1992-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA933567B true ZA933567B (en) | 1993-12-13 |
Family
ID=25393634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA933567A ZA933567B (en) | 1992-05-27 | 1993-05-21 | Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0642338B1 (ja) |
| JP (1) | JPH07507299A (ja) |
| KR (1) | KR950701518A (ja) |
| AT (1) | ATE147978T1 (ja) |
| AU (1) | AU672401B2 (ja) |
| CA (1) | CA2135752C (ja) |
| DE (1) | DE69307702T2 (ja) |
| DK (1) | DK0642338T3 (ja) |
| ES (1) | ES2101311T3 (ja) |
| GR (1) | GR3022608T3 (ja) |
| HU (1) | HUT72316A (ja) |
| MX (1) | MX9303074A (ja) |
| NO (1) | NO944524L (ja) |
| WO (1) | WO1993024120A1 (ja) |
| ZA (1) | ZA933567B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09505276A (ja) * | 1993-09-24 | 1997-05-27 | メレルファーマスーティカルズ インコーポレイテッド | （Ｅ）−２−（ｐ−フルオロフェネチル）−３−フルオロアリルアミンを含有するトランスダーマルデバイス、およびアルツハイマー病の処置に於けるその使用方法 |
| US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
| US5599986A (en) * | 1994-09-29 | 1997-02-04 | Hoechst Marion Roussel Inc. | Process for the preparation of alkali metal salts of diformylamide |
| US20070293548A1 (en) * | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
| EP1870097A1 (en) * | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ224982A (en) * | 1987-06-16 | 1990-08-28 | Merrell Dow Pharma | E-2-(p-fluorophenethyl)-3-fluoroallylamine and its pharmaceutical compositions |
-
1993
- 1993-04-14 ES ES93909326T patent/ES2101311T3/es not_active Expired - Lifetime
- 1993-04-14 DK DK93909326.6T patent/DK0642338T3/da active
- 1993-04-14 EP EP93909326A patent/EP0642338B1/en not_active Expired - Lifetime
- 1993-04-14 KR KR1019940704236A patent/KR950701518A/ko not_active Application Discontinuation
- 1993-04-14 AU AU39782/93A patent/AU672401B2/en not_active Ceased
- 1993-04-14 HU HU9403384A patent/HUT72316A/hu unknown
- 1993-04-14 JP JP6500520A patent/JPH07507299A/ja active Pending
- 1993-04-14 CA CA002135752A patent/CA2135752C/en not_active Expired - Fee Related
- 1993-04-14 AT AT93909326T patent/ATE147978T1/de active
- 1993-04-14 DE DE69307702T patent/DE69307702T2/de not_active Expired - Fee Related
- 1993-04-14 WO PCT/US1993/003522 patent/WO1993024120A1/en active IP Right Grant
- 1993-05-21 ZA ZA933567A patent/ZA933567B/xx unknown
- 1993-05-26 MX MX9303074A patent/MX9303074A/es not_active IP Right Cessation
-
1994
- 1994-11-25 NO NO944524A patent/NO944524L/no not_active Application Discontinuation
-
1997
- 1997-02-19 GR GR970400294T patent/GR3022608T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3022608T3 (en) | 1997-05-31 |
| DK0642338T3 (da) | 1997-02-10 |
| WO1993024120A1 (en) | 1993-12-09 |
| DE69307702T2 (de) | 1997-05-28 |
| HU9403384D0 (en) | 1995-02-28 |
| ATE147978T1 (de) | 1997-02-15 |
| AU672401B2 (en) | 1996-10-03 |
| CA2135752A1 (en) | 1993-12-09 |
| EP0642338A1 (en) | 1995-03-15 |
| DE69307702D1 (de) | 1997-03-06 |
| JPH07507299A (ja) | 1995-08-10 |
| EP0642338B1 (en) | 1997-01-22 |
| AU3978293A (en) | 1993-12-30 |
| ES2101311T3 (es) | 1997-07-01 |
| NO944524D0 (no) | 1994-11-25 |
| KR950701518A (ko) | 1995-04-28 |
| NO944524L (no) | 1994-11-25 |
| HUT72316A (en) | 1996-04-29 |
| MX9303074A (es) | 1994-01-31 |
| CA2135752C (en) | 1998-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0735870A4 (en) | USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
| GR3029670T3 (en) | Treatment of macular degeneration. | |
| HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
| GB2285219A (en) | Use of norastemizole for the treatment of allergic disorders | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
| PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
| IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
| ZA933567B (en) | Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease | |
| NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
| GR3036260T3 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
| FI953725A (fi) | Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi | |
| LV5179A3 (lv) | Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai | |
| GB9010389D0 (en) | Pharmaceutical formulations for the treatment of peripheral vascular diseases | |
| SI0664121T1 (en) | Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of atherosclerose and ischaemic heart disease |